Human medicines European public assessment report (EPAR): MabThera, rituximab, Date of authorisation: 02/06/1998, Revision: 63, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 3 April 2025 - 15:40

Human medicines European public assessment report (EPAR): MabThera, rituximab, Date of authorisation: 02/06/1998, Revision: 63, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/mabthera

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters